Skip to Content

Notice

Memorandum of Understanding Between the Food and Drug Administration, United States Department of Health and Human Services, the Animal and Plant Health Inspection Service, the United States Department of Agriculture, and The National Institutes of Health, United States Department of Health and Human Services Concerning Laboratory Animal Welfare

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The purpose of this Memorandum of Understanding (MOU) is to set forth an agreement between the Animal and Plant Health Inspection Service, U.S. Department of Agriculture, and the National Institutes of Health, U.S. Department of Health and Human Services concerning Laboratory Animal Welfare and FDA (collectively “the Parties”, or individually as a “Party”) regarding the framework for reciprocal cooperation which will assist each agency in meeting its responsibilities in promoting proper laboratory animal care and welfare. This MOU replaces 225-83-8400.

DATES:

The agreement became effective February 14, 2006.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

For FDA: Rodney T. Allnut, Office of Enforcement, Office of Regulatory Affairs, Food and Drug Administration, HFC-230, rm. 126, 15800 Crabbs Branch, Rockville, MD 20855, 240-632-6848, FAX: 240-632-6861.

For USDA: Chester Gipson, Animal and Plant Health Inspection Service, U.S. Department of Agriculture, 4700 River Rd., Unit 97, rm. 6A-16, Riverdale, MD 20737-1234, 301-734-4980, FAX: 301-734-4993.

For NIH: Carol Wigglesworth, Office of Laboratory Animal Welfare, Office of Extramural Research, National Institutes of Health, Rockwall I, suite 1050, MSC 7982, 6705 Rockledge Dr., Bethesda, MD 20892-7982, 301-496-7163, FAX: 301-402-2803.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

Start Signature

Dated: April 26, 2006.

Jeffrey Shuren,

Assistant Commissioner for Policy.

End Signature Start Printed Page 26096

Start Printed Page 26097

Start Printed Page 26098

Start Printed Page 26099

Start Printed Page 26100

Start Printed Page 26101

F>End Supplemental Information

BILLING CODE 4160-01-S

[FR Doc. 06-4184 Filed 5-2-06; 8:45 am]

BILLING CODE 4160-01-C